Synthesis and antiviral evaluation of novel cyclopropyl nucleosides, phosphonate nucleosides and phosphonic acid nucleosides

Archiv der Pharmazie

Volumn 339, Issue 9, 2006, Pages 507-512

  Oh, Chang Hyun ^a   Hong, Joon Hee ^b  

^a Korea Institute of Science and Technology   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Antiviral agents; Branched nucleoside; Cyclopropyl nucleoside, Phosphonate nucleoside; Phosphonic acid nucleoside

Indexed keywords

1 [2 (DIISOPROPOXYPHOSPHORYLMETHOXYMETHYL) 2 PHENYLCYCLOPROPYLMETHYL]CYTOSINE; 1 [2 (DIISOPROPOXYPHOSPHORYLMETHOXYMETHYL) 2 PHENYLCYCLOPROPYLMETHYL]THYMINE; 1 [2 (DIISOPROPOXYPHOSPHORYLMETHOXYMETHYL) 2 PHENYLCYCLOPROPYLMETHYL]URACIL; 1 [2 (HYDROXYMETHYL) 2 PHENYLCYCLOPROPYLMETHYL]CYTOSINE; 1 [2 (HYDROXYMETHYL) 2 PHENYLCYCLOPROPYLMETHYL]THYMINE; 1 [2 (HYDROXYMETHYL) 2 PHENYLCYCLOPROPYLMETHYL]URACIL; 1 [2 (HYDROXYMETHYL) 2 PHENYLCYCLOPROPYLMETHYLPHOSPHONIC ACID]CYTOSINE; 1 [2 (HYDROXYMETHYL) 2 PHENYLCYCLOPROPYLMETHYLPHOSPHONIC ACID]THYMINE; 1 [2 (HYDROXYMETHYL) 2 PHENYLCYCLOPROPYLMETHYLPHOSPHONIC ACID]URACIL; 9 [2 (DIISOPROPOXYPHOSPHORYLMETHOXYMETHYL) 2 PHENYLCYCLOPROPYLMETHYL]ADENINE; 91 [2 (HYDROXYMETHYL) 2 PHENYLCYCLOPROPYLMETHYL]ADENINE; ACICLOVIR; ADENINE; ANTIVIRUS AGENT; CYCLOPROPANE DERIVATIVE; CYTOSINE; GANCICLOVIR; MESYLIC ACID; NUCLEOSIDE DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; THYMINE; UNCLASSIFIED DRUG; URACIL; ZIDOVUDINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; DESILYLATION; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL;

ANTIVIRAL AGENTS; CELL LINE; CYCLOPROPANES; CYTOMEGALOVIRUS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NUCLEOSIDES; PHOSPHONIC ACIDS;

EID: 33749573167     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200600031     Document Type: Article

References (13)

1. A. T. Ashton, L. C. Meurer, C. L. Cantone, A. K. Field, et al., J. Med. Chem. 1988, 31, 2304-2315.
2. Y. L. Qiu, A. Hempel, N. Camerman, A. Camerman, et al., J. Med. Chem. 1998, 41, 5257-5264.
3. Y. L. Qiu, M. B. Ksebati, R. G. Ptak, B. Y. Fan, et al., J. Med. Chem. 1998, 41, 10-23.
4. T. Sekiyama, S. Hatsuya, Y. Tanaka, M. Uchiyama, et al., J. Med. Chem. 1998, 41, 1284-1298.
5. E. De Clercq, T. Sakuma, M. Baba, R. Pauwels, et al., Antiviral Res. 1987, 8, 262-272.
6. B. L. Robbins, R. V. Srinivas, N. Bischofberger, A. Fridland, Antimicrob. Agents Chemother. 1998, 42, 612-617.
7. S. Noble, K. L. Goa, Drugs 1999, 58, 479487.
8. J. E. Starrett, D. R. Tortolani, J. Russell, M. J. M. Hitchcock, et al., J. Med. Chem. 1994, 37, 1857-1864.
9. N. Bischofberger, R. J. Jones, Antiviral Res. 1995, 27, 1-17.
10. J. H. Hong, O. H. Ko, Bull Korean Chem. Soc. 2003, 24, 1284-1288.
11. N. Hossain, J. Rozenski, E. De Clercq, P. Herdewijn, Tetrahedron 1996, 52, 13655-13670.
12. H. I. El Subbagh, S. Racha, E. Abushanab, R. P. Panzica, J. Org. Chem. 1996, 61, 890-894.
13. O. H. Ko, J. H. Hong, Arch. Pharm. Pharm. Med. Chem. 2004, 337, 579-586.